Press Releases

Artificial intelligence is moving from isolated pilots into the core of how healthcare is delivered, documented, diagnosed and administered. According to IG Transformation Partners (IGTPS), the global AI in healthcare market was valued at USD 37.0 billion in 2025 and is projected to reach USD 764.5 billion by 2034, growing at a CAGR of 40.0% during 2026 to 2034. The complete AI in healthcare market report provides the full forecast, segmentation and company analysis.

This article covers the market’s scope, growth drivers, regulatory context, segments, regions and competitive dynamics, along with the strategic implications for providers, vendors and investors.

Get the Full AI in Healthcare Market Report

Access forecasts to 2034, segmentation by component, technology, application and end user, regional and country analysis, company profiles and recent developments. Use the findings to guide investment, product and partnership decisions.

Access the Full Market Report https://www.igtps.com/report/ai-in-healthcare-market

What Is the AI in Healthcare Market?

The AI in healthcare market covers software, hardware and services that apply machine learning, natural language processing, computer vision and generative AI across diagnostic imaging, clinical documentation, drug discovery and administrative workflows.

IGTPS segments the market by component (software, hardware, services), technology (machine learning, natural language processing, computer vision, context-aware computing, robotic process automation), application (robot-assisted surgery, medical imaging and diagnostics, clinical decision support, drug discovery and development, virtual health assistants, administrative workflow automation), end user (hospitals and healthcare providers, pharmaceutical and biotechnology companies, diagnostic centers, healthcare payers, patients) and region.

The market is shifting from narrow, single-purpose diagnostic algorithms toward integrated AI platforms that support multiple clinical and administrative workflows across an entire health system.

AI in Healthcare Market Size, Share and Forecast

IGTPS values the market at USD 37 billion in 2025 and USD 51.8 billion in 2026, rising to USD 764.5 billion by 2034. That is roughly a 21-fold increase from the 2025 base, one of the steepest trajectories in healthcare technology.

Key Market Trends and Developments

Ambient Generative AI for Clinical Documentation

Ambient AI scribes are deployed across outpatient clinics and hospital departments to listen to patient-clinician conversations and draft structured notes. This reduces after-hours documentation, a leading contributor to clinician burnout.

LLMs Embedded in EHR Workflows

Technology vendors are embedding large language models directly into electronic health record workflows, enabling automated coding, order entry and chart summarization. Health systems increasingly demand measurable productivity gains within a single annual technology budget cycle.

Expansion Into Adjacent Workflows

Established EHR platforms and specialized ambient documentation companies are expanding into revenue cycle management and patient messaging automation. Abridge was ranked top vendor for Ambient AI in Revenue Cycle Management for the second consecutive year in the Best in KLAS Software and Services report.

Regulatory Clarity

The FDA issued draft guidance in January 2025 on lifecycle management of AI-enabled device software. In the United Kingdom, the AI Diagnostic Fund committed an additional GBP 20 million in June 2026 to expand AI-powered chest X-ray analysis across NHS hospitals.

What Is Driving AI in Healthcare Market Growth?

Rising FDA Authorizations and Government Investment

Regulatory agencies are accelerating pathways for AI-enabled diagnostic and imaging software, shortening procurement cycles and encouraging health systems to move from pilot to production. The FDA’s AI-Enabled Medical Device List reached 1,451 total authorizations through the end of 2025, including a record 295 new clearances that year. National governments are also funding AI diagnostic infrastructure, which lowers the financial barrier for smaller hospitals.

Workforce Shortages

Shortages of radiologists, pathologists and primary care physicians push health systems toward AI that triages cases and prioritizes urgent findings. IGTPS expects this pressure to intensify over the next decade, sustaining demand for clinical decision support software.

Data Growth and Administrative Burden

Rising healthcare data volumes and documentation burdens tied to value-based reimbursement strengthen the case for automation of coding, prior authorization, scheduling and note generation.

Preview the Report Before You Buy

Request the sample pages to review the report’s structure, tables and analysis, and confirm it matches your research needs.

Download Free Sample Pages https://www.igtps.com/download-free-sample/ai-in-healthcare-market?P=03

Market Restraints and Challenges

IGTPS analysis points to several constraints.

• High competitive intensity. Low switching costs for point solutions keep competition high, and IGTPS expects gradual consolidation.
• Clinical validation and procurement scrutiny. Success depends on regulatory clearance track record, integration depth and demonstrated outcome data.
• Model governance. Many health systems lack in-house data science teams to manage model drift, bias auditing and interoperability with legacy EHRs.
• Integration complexity. Deep EHR integration is a key success factor and a common barrier to scale.
• Capital limits for smaller providers. Enterprise AI licensing costs can be prohibitive, which as-a-service pricing is beginning to address.

Market Opportunities and Future Outlook

AI-Enabled Drug Discovery

Pharmaceutical companies are entering multi-year computing and data-sharing partnerships to accelerate target identification, molecular design and clinical trial simulation. NVIDIA and Eli Lilly announced a five-year, USD 1 billion joint research partnership to build dedicated AI computing infrastructure for drug discovery.

Emerging Markets

Asia-Pacific, Latin America and the Middle East remain under-penetrated for enterprise AI healthcare tools despite rapid hospital digitization. Vendors that localize language and pricing can gain first-mover advantage.

As-a-Service Models

As-a-service pricing lowers upfront cost for mid-sized hospitals and clinics, widening the addressable base toward community hospitals and rural providers.

AI in Healthcare Market Segmentation Analysis

Readers can preview how these segments are presented by requesting the free sample pages.

By Component

Software led because algorithms, decision support engines and generative AI applications can be deployed across existing imaging equipment and EHR systems without costly hardware replacement, and subscription pricing supports recurring revenue. Services are projected to grow fastest as hospitals need implementation, workflow integration, algorithm validation and ongoing model monitoring.

By Technology

Machine learning led as the foundation for most commercially deployed applications, backed by more than a decade of clinical validation. Natural language processing is projected to grow fastest, driven by generative AI ambient documentation that converts spoken conversations into structured records and is widening from primary care into surgery and emergency medicine. Computer vision, context-aware computing and robotic process automation complete the segment.

By Application

Robot-assisted surgery led because of sustained hospital investment in AI-guided surgical platforms, established reimbursement pathways and more than two decades of procedure data. Administrative workflow automation is projected to grow fastest because generative AI tools for coding, prior authorization, scheduling and note generation deliver measurable savings within months, offering a lower-risk entry point than diagnostics. Medical imaging and diagnostics, clinical decision support, drug discovery and virtual health assistants complete the segment.

By End User

Hospitals and healthcare providers led as the primary site where imaging, documentation and surgical AI are deployed at scale. Pharmaceutical and biotechnology companies are projected to grow fastest as drug developers rely on AI for target identification, molecular design and trial patient matching. Diagnostic centers, payers and patients complete the segmentation.

Regional Analysis

North America leads because of advanced healthcare IT infrastructure, high EHR adoption and a concentration of AI vendors in the United States. The FDA’s AI-Enabled Medical Device List has authorized more than 1,400 devices to date, and well-capitalized health systems in the United States and Canada scale generative AI for documentation, imaging and administration faster than most regions.

Asia-Pacific is projected to grow fastest, supported by government digital health programs and growing hospital networks. China’s national digitization initiatives create scale for AI imaging and administrative tools, Japan and South Korea advance robotics and precision diagnostics, and India is emerging as a fast-growing country market with national digital health infrastructure and a base of diagnostic AI startups.

Europe, Latin America, and the Middle East and Africa are also covered, with Germany, Brazil and Saudi Arabia identified as the largest country markets in their regions.

Competitive Landscape and Key Companies

IGTPS describes the market as fragmented, with large technology companies providing cloud, computing and AI infrastructure alongside specialized clinical software vendors. Profiled players include Microsoft, NVIDIA, Alphabet, Amazon, Oracle, Siemens Healthineers, GE HealthCare, Philips, Tempus AI, PathAI, Aidoc, Viz.ai, Abridge, Suki AI, Corti, Ada Health and Butterfly Network.

Recent developments cited by IGTPS:

• March 2025: Memorial Sloan Kettering adopted Abridge’s platform for a rollout across 2025 and 2026.
• August 2025: PathAI announced a multi-year collaboration with Moffitt Cancer Center to deploy its AISight Dx platform, building on FDA clearance for primary diagnosis in June 2025.
• January 2026: NVIDIA and Eli Lilly announced their USD 1 billion drug discovery partnership.
• August 2026: Suki AI launched Suki Dictation, integrated with Epic and MEDITECH.

Strategic Implications for Industry Participants

Vendors should prioritize platform expansion, regulatory clearance depth, EHR integration and published outcome data, and expect consolidation as larger firms acquire specialized AI companies.

Hospitals and health systems may find administrative automation a lower-risk entry point, then expand into imaging and decision support as governance matures.

Pharmaceutical companies can use AI partnerships to shorten discovery cycles and improve trial patient matching.

Investors should note the growth of services, natural language processing and Asia-Pacific, and the scale of partnerships between infrastructure providers and healthcare organizations.

Why Choose IG Transformation Partners

IG Transformation Partners is a market research and industry intelligence provider serving life science, ICT, consumer products and other industries. This report offers 180 to 190 pages and 60 to 70 market tables, delivered as a PDF report with a data sheet and analyst support. IGTPS also offers customized research and consulting services. Its published strengths include strong industry focus, comprehensive reports, value chain analysis, growth dynamics, quality assurance and regular report updates.

Conclusion

The AI in healthcare market is projected to grow from USD 37.0 billion in 2025 to USD 764.5 billion by 2034 at a 40.0% CAGR. Regulatory clarity, workforce shortages and generative AI for documentation and administration are driving adoption, while drug discovery partnerships and emerging markets add new revenue streams. Organizations that combine regulatory track record, deep EHR integration and demonstrated outcomes will be best positioned in a fragmented and fast-consolidating field.

Frequently Asked Questions

What is the AI in healthcare market?

It covers software, hardware and services that apply machine learning, natural language processing, computer vision and generative AI across diagnostic imaging, clinical documentation, drug discovery and administrative healthcare workflows.

How big is the AI in healthcare market?

IGTPS values the market at USD 37.0 billion in 2025 and USD 51.8 billion in 2026. It is projected to reach USD 764.5 billion by 2034, driven by data growth, workforce shortages and regulatory clearance pathways.

What is the CAGR of the AI in healthcare market?

IGTPS projects a CAGR of 40.0% for 2026 to 2034. Growth reflects accelerating hospital investment in generative AI for documentation, imaging and administrative automation.

What is the forecast for AI in healthcare through 2034?

The market is forecast to grow from USD 37.0 billion in 2025 to USD 764.5 billion by 2034. IGTPS expects services, natural language processing, administrative workflow automation and Asia-Pacific to grow fastest.

What are the key trends in AI in healthcare?

Key trends include ambient generative AI for documentation, large language models embedded in EHR workflows and expansion into revenue cycle and patient messaging automation, alongside growing regulatory clarity such as the FDA’s January 2025 draft guidance.

What is driving AI in healthcare market growth?

Drivers include rising FDA authorizations, with 1,451 total through 2025 and 295 new clearances that year, plus government diagnostic investment and shortages of radiologists, pathologists and primary care physicians.

Which segments lead the AI in healthcare market?

Software, machine learning, robot-assisted surgery and hospitals and healthcare providers led in 2025. Services, natural language processing, administrative workflow automation and pharmaceutical and biotechnology companies are projected to grow fastest.

Which region dominates the AI in healthcare market?

North America held the largest share in 2025 at 43%, supported by IT infrastructure, EHR adoption and US-based vendors. Europe held 27%, and Asia-Pacific is projected to grow fastest.

Who are the key companies in AI in healthcare?

IGTPS profiles Microsoft, NVIDIA, Alphabet, Amazon, Oracle, Siemens Healthineers, GE HealthCare, Philips, Tempus AI, PathAI, Aidoc, Viz.ai, Abridge, Suki AI, Corti, Ada Health and Butterfly Network. The market is fragmented.

What are the main challenges in AI in healthcare?

Challenges include intense competition with low switching costs for point solutions, the need for clinical validation, model governance and bias auditing, EHR integration complexity and capital limits for smaller providers.

Related IGTPS Reports

AI Diagnostics Market
Relevant for readers tracking AI-enabled triage, screening and companion diagnostics.
Explore the Full Report
https://www.igtps.com/report/ai-diagnostics-market

AI in Medical Imaging Market
Relevant for readers following AI detection, triage and reporting in radiology.
Explore the Full Report
https://www.igtps.com/report/ai-in-medical-imaging-market

AI-Powered Clinical Documentation Market
Relevant for readers assessing ambient AI scribes and documentation automation.
Explore the Full Report
https://www.igtps.com/report/ai-powered-clinical-documentation-market

AI Medical Imaging Software Market
Relevant for readers comparing AI imaging software adoption and FDA authorization trends.
Explore the Full Report
https://www.igtps.com/report/ai-medical-imaging-software-market